MedTrace Logo

Continuous Adductor Canal Block With a New Catheter - Primary Placement and Secondary Repositioning

NCT02657603 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 16

Last updated 2017-10-19

No results posted yet for this study

Summary

This is a single center, randomized, blinded trial in healthy volunteers. The volunteers will receive bilateral placement of the new catheter corresponding to the adductor canal. Each volunteer will have a catheter placed in the adductor canal in both legs. The catheters are randomized to be placed either in the long-axis or short-axis plane of the adductor canal. Both catheters will be injected with local analgesics (LA). Allocation will be blinded to the volunteer and the investigator assessing sensory function. The volunteers will be sent home with the catheter in situ and return the following day. Injection with LA is repeated and sensory function is tested again. Furthermore catheter position is determined with ultrasound during injection. If sensory function is not affected by injection of LA then the catheter is visualized with ultrasound and repositioned followed by a second injection of LA and subsequent assessment of sensory function

Conditions

Interventions

DRUG

Lidocaine

Lidocaine injected through the new Catheter (LAX)

DRUG

Lidocaine

Lidocaine injected through the new Catheter (SAX)

PROCEDURE

LAX insertion of catheter

ultra sound guided cather insertion in the long axis (LAX) of the adductor canal

PROCEDURE

SAX insertion of catheter

ultra sound guided cather insertion in the short axis (SAX) of the adductor canal

Sponsors & Collaborators

  • Kai Henrik Wiborg Lange

    lead OTHER

Principal Investigators

  • Tobias S Lyngeraa, MD · Nordsjaellands Hospital

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-01-31
Primary Completion
2016-03-31
Completion
2016-03-31

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02657603 on ClinicalTrials.gov